

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 4.34969835 |
| 2 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.25508174 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.24729711 |
| 4 | glutamate secretion (GO:0014047) | 4.01342124 |
| 5 | locomotory exploration behavior (GO:0035641) | 3.91149261 |
| 6 | L-amino acid import (GO:0043092) | 3.88590905 |
| 7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.85504147 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 3.82227524 |
| 9 | sodium ion export (GO:0071436) | 3.80973799 |
| 10 | amino acid import (GO:0043090) | 3.75769888 |
| 11 | cellular potassium ion homeostasis (GO:0030007) | 3.62604829 |
| 12 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.56278650 |
| 13 | activation of protein kinase A activity (GO:0034199) | 3.43827244 |
| 14 | regulation of synaptic vesicle transport (GO:1902803) | 3.38021208 |
| 15 | positive regulation of neurotransmitter transport (GO:0051590) | 3.28529135 |
| 16 | macroautophagy (GO:0016236) | 3.24227111 |
| 17 | layer formation in cerebral cortex (GO:0021819) | 3.19446028 |
| 18 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.15644518 |
| 19 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.13702314 |
| 20 | synaptic vesicle endocytosis (GO:0048488) | 3.11865400 |
| 21 | neurotransmitter secretion (GO:0007269) | 3.11588764 |
| 22 | neuronal ion channel clustering (GO:0045161) | 3.09072543 |
| 23 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.07133483 |
| 24 | vesicle transport along microtubule (GO:0047496) | 3.01277236 |
| 25 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.97900692 |
| 26 | COPI coating of Golgi vesicle (GO:0048205) | 2.96241843 |
| 27 | Golgi transport vesicle coating (GO:0048200) | 2.96241843 |
| 28 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.93469696 |
| 29 | proline transport (GO:0015824) | 2.92643583 |
| 30 | regulation of synapse structural plasticity (GO:0051823) | 2.92045847 |
| 31 | cell communication by electrical coupling (GO:0010644) | 2.89204602 |
| 32 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.89005577 |
| 33 | regulation of ARF protein signal transduction (GO:0032012) | 2.88468486 |
| 34 | alanine transport (GO:0032328) | 2.87994239 |
| 35 | calcium ion-dependent exocytosis (GO:0017156) | 2.86801910 |
| 36 | positive regulation of membrane potential (GO:0045838) | 2.86565367 |
| 37 | positive regulation of dendritic spine development (GO:0060999) | 2.83012723 |
| 38 | potassium ion import (GO:0010107) | 2.80052044 |
| 39 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.77058414 |
| 40 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.75686867 |
| 41 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.75035163 |
| 42 | cerebellar Purkinje cell layer development (GO:0021680) | 2.70994388 |
| 43 | regulation of synapse maturation (GO:0090128) | 2.69452801 |
| 44 | dendritic spine organization (GO:0097061) | 2.67678661 |
| 45 | potassium ion homeostasis (GO:0055075) | 2.67278649 |
| 46 | exploration behavior (GO:0035640) | 2.66742925 |
| 47 | cerebellar granule cell differentiation (GO:0021707) | 2.65790787 |
| 48 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.65529211 |
| 49 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.65041673 |
| 50 | dendritic spine morphogenesis (GO:0060997) | 2.64976717 |
| 51 | negative regulation of inclusion body assembly (GO:0090084) | 2.63842028 |
| 52 | vocalization behavior (GO:0071625) | 2.61080305 |
| 53 | acidic amino acid transport (GO:0015800) | 2.60231744 |
| 54 | regulation of early endosome to late endosome transport (GO:2000641) | 2.59515063 |
| 55 | adenosine receptor signaling pathway (GO:0001973) | 2.58853189 |
| 56 | vesicle docking involved in exocytosis (GO:0006904) | 2.58818210 |
| 57 | protein targeting to Golgi (GO:0000042) | 2.58781319 |
| 58 | gamma-aminobutyric acid transport (GO:0015812) | 2.58279338 |
| 59 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.57582566 |
| 60 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.57298648 |
| 61 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.56885729 |
| 62 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.56459257 |
| 63 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.55773004 |
| 64 | regulation of exocytosis (GO:0017157) | 2.53816004 |
| 65 | signal complex assembly (GO:0007172) | 2.53084608 |
| 66 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.52909008 |
| 67 | positive regulation of vesicle fusion (GO:0031340) | 2.50691755 |
| 68 | membrane depolarization during action potential (GO:0086010) | 2.50281395 |
| 69 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.49016460 |
| 70 | detection of calcium ion (GO:0005513) | 2.48706414 |
| 71 | long term synaptic depression (GO:0060292) | 2.48403422 |
| 72 | axon ensheathment in central nervous system (GO:0032291) | 2.47981241 |
| 73 | central nervous system myelination (GO:0022010) | 2.47981241 |
| 74 | membrane repolarization (GO:0086009) | 2.47808197 |
| 75 | neurotransmitter transport (GO:0006836) | 2.47735574 |
| 76 | positive regulation of protein dephosphorylation (GO:0035307) | 2.47652737 |
| 77 | chemosensory behavior (GO:0007635) | 2.45505879 |
| 78 | organelle transport along microtubule (GO:0072384) | 2.45214888 |
| 79 | dicarboxylic acid transport (GO:0006835) | 2.44659685 |
| 80 | establishment of protein localization to Golgi (GO:0072600) | 2.44468715 |
| 81 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.44134319 |
| 82 | long-term memory (GO:0007616) | 2.44070692 |
| 83 | cell communication involved in cardiac conduction (GO:0086065) | 2.43897491 |
| 84 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.43191143 |
| 85 | neuromuscular process controlling balance (GO:0050885) | 2.40667683 |
| 86 | regulation of synaptic transmission (GO:0050804) | 2.40475577 |
| 87 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.40287227 |
| 88 | neuromuscular process controlling posture (GO:0050884) | 2.40115622 |
| 89 | cellular sodium ion homeostasis (GO:0006883) | 2.39534282 |
| 90 | positive regulation of synapse maturation (GO:0090129) | 2.39148212 |
| 91 | regulation of neurotransmitter secretion (GO:0046928) | 2.39079497 |
| 92 | response to manganese ion (GO:0010042) | 2.38396350 |
| 93 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.38355195 |
| 94 | positive regulation of exocytosis (GO:0045921) | 2.37909109 |
| 95 | glycine transport (GO:0015816) | 2.37876565 |
| 96 | long-term synaptic potentiation (GO:0060291) | 2.37270463 |
| 97 | synaptic vesicle transport (GO:0048489) | 2.36805985 |
| 98 | establishment of synaptic vesicle localization (GO:0097480) | 2.36805985 |
| 99 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.35183706 |
| 100 | trivalent inorganic cation transport (GO:0072512) | 2.34807842 |
| 101 | ferric iron transport (GO:0015682) | 2.34807842 |
| 102 | synaptic transmission, glutamatergic (GO:0035249) | 2.30988414 |
| 103 | regulation of postsynaptic membrane potential (GO:0060078) | 2.30553609 |
| 104 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.29863529 |
| 105 | neuronal action potential propagation (GO:0019227) | 2.29061226 |
| 106 | regulation of synaptic plasticity (GO:0048167) | 2.28564212 |
| 107 | L-glutamate transport (GO:0015813) | 2.28528676 |
| 108 | barbed-end actin filament capping (GO:0051016) | 2.28380619 |
| 109 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.27641938 |
| 110 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.27641938 |
| 111 | acrosome reaction (GO:0007340) | 2.26733364 |
| 112 | insulin secretion (GO:0030073) | 2.26226216 |
| 113 | regulation of neurotransmitter levels (GO:0001505) | 2.25993380 |
| 114 | vesicle docking (GO:0048278) | 2.24751107 |
| 115 | regulation of neurotransmitter transport (GO:0051588) | 2.24574355 |
| 116 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.24028996 |
| 117 | response to dietary excess (GO:0002021) | 2.23755286 |
| 118 | dendrite morphogenesis (GO:0048813) | 2.23714912 |
| 119 | axon cargo transport (GO:0008088) | 2.22855368 |
| 120 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.22651025 |
| 121 | regulation of regulated secretory pathway (GO:1903305) | 2.22260814 |
| 122 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.22260581 |
| 123 | positive regulation of Rap GTPase activity (GO:0032854) | 2.21962752 |
| 124 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.21953792 |
| 125 | protein localization to synapse (GO:0035418) | 2.21371321 |
| 126 | signal release (GO:0023061) | 2.21264973 |
| 127 | regulation of vesicle fusion (GO:0031338) | 2.21184049 |
| 128 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.20990067 |
| 129 | prepulse inhibition (GO:0060134) | 2.20580897 |
| 130 | sperm motility (GO:0030317) | 2.20406642 |
| 131 | neuron-neuron synaptic transmission (GO:0007270) | 2.19948444 |
| 132 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.17342809 |
| 133 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.16759910 |
| 134 | transferrin transport (GO:0033572) | 2.16746941 |
| 135 | positive regulation of potassium ion transport (GO:0043268) | 2.16215545 |
| 136 | mating behavior (GO:0007617) | 2.15654122 |
| 137 | glutamate receptor signaling pathway (GO:0007215) | 2.14358669 |
| 138 | regulation of inclusion body assembly (GO:0090083) | 2.13764990 |
| 139 | regulation of microtubule-based movement (GO:0060632) | 2.12601628 |
| 140 | cellular response to glucagon stimulus (GO:0071377) | 2.12018322 |
| 141 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.11381567 |
| 142 | regulation of cholesterol homeostasis (GO:2000188) | 2.09219823 |
| 143 | behavioral response to cocaine (GO:0048148) | 2.08780340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.60393003 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.19354346 |
| 3 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.11970740 |
| 4 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.11211650 |
| 5 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.05760304 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.05530606 |
| 7 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.99677438 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.95059226 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.87517009 |
| 10 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.80094761 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.79954469 |
| 12 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.71675097 |
| 13 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67860214 |
| 14 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.67464291 |
| 15 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.66638145 |
| 16 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.62581651 |
| 17 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.61139691 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.60408436 |
| 19 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.60052532 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.58389408 |
| 21 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.57380030 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.55653189 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.53892158 |
| 24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.52912865 |
| 25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.52912865 |
| 26 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.52192372 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49619072 |
| 28 | KDM2B_26808549_Chip-Seq_K562_Human | 1.46008990 |
| 29 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.45423454 |
| 30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.45260896 |
| 31 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.45148129 |
| 32 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.42258322 |
| 33 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.41454673 |
| 34 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.40542612 |
| 35 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.39997808 |
| 36 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.39559092 |
| 37 | P68_20966046_ChIP-Seq_HELA_Human | 1.38497927 |
| 38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.37549339 |
| 39 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.37023930 |
| 40 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.36123234 |
| 41 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.35491452 |
| 42 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.33534422 |
| 43 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.32025408 |
| 44 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29628410 |
| 45 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.27917616 |
| 46 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27418747 |
| 47 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.27229471 |
| 48 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.27001609 |
| 49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.25459938 |
| 50 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.24683550 |
| 51 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24107242 |
| 52 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.23165276 |
| 53 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21877045 |
| 54 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20656239 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.20533714 |
| 56 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19409580 |
| 57 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.18232034 |
| 58 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.16620565 |
| 59 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.15552331 |
| 60 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15321807 |
| 61 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15315470 |
| 62 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.14783866 |
| 63 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.14470176 |
| 64 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14365809 |
| 65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14137702 |
| 66 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13615129 |
| 67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13001281 |
| 68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12915496 |
| 69 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12781799 |
| 70 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.12691763 |
| 71 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.12465996 |
| 72 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.11834084 |
| 73 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11582678 |
| 74 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.11292998 |
| 75 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11268890 |
| 76 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.10904996 |
| 77 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09498777 |
| 78 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09191031 |
| 79 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.07774526 |
| 80 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.07509268 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07439956 |
| 82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05758489 |
| 83 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05690227 |
| 84 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05589395 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04344169 |
| 86 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.03122254 |
| 87 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03061534 |
| 88 | SA1_27219007_Chip-Seq_Bcells_Human | 1.02481601 |
| 89 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.02230005 |
| 90 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01796812 |
| 91 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.01312888 |
| 92 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01082897 |
| 93 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.00972396 |
| 94 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.99073736 |
| 95 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.98467711 |
| 96 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.98265709 |
| 97 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.97942931 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97461036 |
| 99 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96965902 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96906157 |
| 101 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96790861 |
| 102 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.96738212 |
| 103 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.96692076 |
| 104 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.96400458 |
| 105 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.96037520 |
| 106 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.95185990 |
| 107 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95009566 |
| 108 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.94951598 |
| 109 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94706927 |
| 110 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.94704120 |
| 111 | AR_19668381_ChIP-Seq_PC3_Human | 0.93529434 |
| 112 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93477295 |
| 113 | AR_25329375_ChIP-Seq_VCAP_Human | 0.93094261 |
| 114 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.92909497 |
| 115 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.92852781 |
| 116 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92842070 |
| 117 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.92260372 |
| 118 | SPI1_23127762_ChIP-Seq_K562_Human | 0.92190924 |
| 119 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91943934 |
| 120 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91855169 |
| 121 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.91365473 |
| 122 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.91084846 |
| 123 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90764682 |
| 124 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.90393970 |
| 125 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88287826 |
| 126 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.87992714 |
| 127 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.87391390 |
| 128 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87058433 |
| 129 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86903339 |
| 130 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.86814600 |
| 131 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.86602145 |
| 132 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.86188714 |
| 133 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.85859372 |
| 134 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.85071810 |
| 135 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.83021990 |
| 136 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.82933276 |
| 137 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.82855245 |
| 138 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82790646 |
| 139 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.82171741 |
| 140 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.81919332 |
| 141 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81316923 |
| 142 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.80555294 |
| 143 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.80464471 |
| 144 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79774155 |
| 145 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.79204698 |
| 146 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.79204698 |
| 147 | STAT3_23295773_ChIP-Seq_U87_Human | 0.79046055 |
| 148 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.78443240 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.86009253 |
| 2 | MP0009780_abnormal_chondrocyte_physiolo | 3.02718233 |
| 3 | MP0003329_amyloid_beta_deposits | 2.89526706 |
| 4 | MP0004270_analgesia | 2.85254524 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 2.83667339 |
| 6 | MP0005410_abnormal_fertilization | 2.66172836 |
| 7 | MP0002909_abnormal_adrenal_gland | 2.65880320 |
| 8 | MP0001984_abnormal_olfaction | 2.63640591 |
| 9 | MP0009046_muscle_twitch | 2.46869336 |
| 10 | MP0000013_abnormal_adipose_tissue | 2.40510237 |
| 11 | MP0004858_abnormal_nervous_system | 2.32821913 |
| 12 | MP0002063_abnormal_learning/memory/cond | 2.29611294 |
| 13 | MP0002064_seizures | 2.26463315 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.21428130 |
| 15 | MP0004510_myositis | 2.15747837 |
| 16 | MP0008961_abnormal_basal_metabolism | 2.10585371 |
| 17 | MP0003880_abnormal_central_pattern | 2.07904700 |
| 18 | MP0009745_abnormal_behavioral_response | 1.99034358 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 1.98350817 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.96241412 |
| 21 | MP0000604_amyloidosis | 1.91204350 |
| 22 | MP0001968_abnormal_touch/_nociception | 1.91078975 |
| 23 | MP0003303_peritoneal_inflammation | 1.89460733 |
| 24 | MP0002572_abnormal_emotion/affect_behav | 1.86669609 |
| 25 | MP0001501_abnormal_sleep_pattern | 1.75380256 |
| 26 | MP0002272_abnormal_nervous_system | 1.72713149 |
| 27 | MP0004233_abnormal_muscle_weight | 1.68311247 |
| 28 | MP0009840_abnormal_foam_cell | 1.68083257 |
| 29 | MP0002822_catalepsy | 1.62518879 |
| 30 | MP0008260_abnormal_autophagy | 1.62457977 |
| 31 | MP0001440_abnormal_grooming_behavior | 1.61763006 |
| 32 | MP0008569_lethality_at_weaning | 1.56861009 |
| 33 | MP0002736_abnormal_nociception_after | 1.54934821 |
| 34 | MP0001970_abnormal_pain_threshold | 1.51970307 |
| 35 | MP0002090_abnormal_vision | 1.51563544 |
| 36 | MP0008874_decreased_physiological_sensi | 1.48969096 |
| 37 | MP0002733_abnormal_thermal_nociception | 1.48083142 |
| 38 | MP0004811_abnormal_neuron_physiology | 1.47994698 |
| 39 | MP0003633_abnormal_nervous_system | 1.47671836 |
| 40 | MP0003690_abnormal_glial_cell | 1.46838902 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.43992049 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 1.43641824 |
| 43 | MP0004885_abnormal_endolymph | 1.43023470 |
| 44 | MP0004043_abnormal_pH_regulation | 1.41695625 |
| 45 | MP0003075_altered_response_to | 1.41662788 |
| 46 | MP0002735_abnormal_chemical_nociception | 1.39687613 |
| 47 | MP0003879_abnormal_hair_cell | 1.37917051 |
| 48 | MP0002877_abnormal_melanocyte_morpholog | 1.34799573 |
| 49 | MP0001905_abnormal_dopamine_level | 1.28430270 |
| 50 | MP0005365_abnormal_bile_salt | 1.28264895 |
| 51 | MP0000003_abnormal_adipose_tissue | 1.27590438 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 1.27057091 |
| 53 | MP0004130_abnormal_muscle_cell | 1.26283210 |
| 54 | MP0002067_abnormal_sensory_capabilities | 1.26013441 |
| 55 | MP0005464_abnormal_platelet_physiology | 1.24345044 |
| 56 | MP0005451_abnormal_body_composition | 1.23888016 |
| 57 | MP0003634_abnormal_glial_cell | 1.23663634 |
| 58 | MP0000955_abnormal_spinal_cord | 1.23071693 |
| 59 | MP0001486_abnormal_startle_reflex | 1.21287906 |
| 60 | MP0003195_calcinosis | 1.20931610 |
| 61 | MP0005535_abnormal_body_temperature | 1.19485931 |
| 62 | MP0005058_abnormal_lysosome_morphology | 1.19224331 |
| 63 | MP0005409_darkened_coat_color | 1.18344033 |
| 64 | MP0003123_paternal_imprinting | 1.18162841 |
| 65 | MP0003631_nervous_system_phenotype | 1.14895506 |
| 66 | MP0010329_abnormal_lipoprotein_level | 1.13199473 |
| 67 | MP0002184_abnormal_innervation | 1.13171148 |
| 68 | MP0003436_decreased_susceptibility_to | 1.12968011 |
| 69 | MP0005670_abnormal_white_adipose | 1.12415598 |
| 70 | MP0002139_abnormal_hepatobiliary_system | 1.11925852 |
| 71 | MP0003172_abnormal_lysosome_physiology | 1.10630776 |
| 72 | MP0005646_abnormal_pituitary_gland | 1.09014645 |
| 73 | MP0001502_abnormal_circadian_rhythm | 1.06503915 |
| 74 | MP0002557_abnormal_social/conspecific_i | 1.04032021 |
| 75 | MP0005623_abnormal_meninges_morphology | 1.02870633 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 1.01263263 |
| 77 | MP0005386_behavior/neurological_phenoty | 1.00753906 |
| 78 | MP0004924_abnormal_behavior | 1.00753906 |
| 79 | MP0002229_neurodegeneration | 0.98836210 |
| 80 | MP0002066_abnormal_motor_capabilities/c | 0.98353353 |
| 81 | MP0002118_abnormal_lipid_homeostasis | 0.97266128 |
| 82 | MP0003705_abnormal_hypodermis_morpholog | 0.96918583 |
| 83 | MP0005360_urolithiasis | 0.96886417 |
| 84 | MP0005187_abnormal_penis_morphology | 0.95730288 |
| 85 | MP0010386_abnormal_urinary_bladder | 0.95426601 |
| 86 | MP0000343_altered_response_to | 0.95320789 |
| 87 | MP0004036_abnormal_muscle_relaxation | 0.95153884 |
| 88 | MP0000751_myopathy | 0.94401867 |
| 89 | MP0005423_abnormal_somatic_nervous | 0.93194685 |
| 90 | MP0004084_abnormal_cardiac_muscle | 0.92292761 |
| 91 | MP0002882_abnormal_neuron_morphology | 0.91650153 |
| 92 | MP0003632_abnormal_nervous_system | 0.87419856 |
| 93 | MP0000920_abnormal_myelination | 0.87350671 |
| 94 | MP0001944_abnormal_pancreas_morphology | 0.86609555 |
| 95 | MP0001765_abnormal_ion_homeostasis | 0.86505552 |
| 96 | MP0002254_reproductive_system_inflammat | 0.85836621 |
| 97 | MP0006082_CNS_inflammation | 0.85527716 |
| 98 | MP0000747_muscle_weakness | 0.84802322 |
| 99 | MP0001299_abnormal_eye_distance/ | 0.83738000 |
| 100 | MP0002693_abnormal_pancreas_physiology | 0.83030915 |
| 101 | MP0003045_fibrosis | 0.82244496 |
| 102 | MP0004085_abnormal_heartbeat | 0.82082570 |
| 103 | MP0003300_gastrointestinal_ulcer | 0.81979734 |
| 104 | MP0010368_abnormal_lymphatic_system | 0.81129264 |
| 105 | MP0005448_abnormal_energy_balance | 0.79866776 |
| 106 | MP0004947_skin_inflammation | 0.77730648 |
| 107 | MP0003453_abnormal_keratinocyte_physiol | 0.77227797 |
| 108 | MP0002069_abnormal_eating/drinking_beha | 0.76891238 |
| 109 | MP0005166_decreased_susceptibility_to | 0.76765379 |
| 110 | MP0002796_impaired_skin_barrier | 0.76252660 |
| 111 | MP0001958_emphysema | 0.74695805 |
| 112 | MP0002998_abnormal_bone_remodeling | 0.73943936 |
| 113 | MP0005165_increased_susceptibility_to | 0.73768826 |
| 114 | MP0003283_abnormal_digestive_organ | 0.73479028 |
| 115 | MP0000778_abnormal_nervous_system | 0.73442559 |
| 116 | MP0005551_abnormal_eye_electrophysiolog | 0.73342170 |
| 117 | MP0005375_adipose_tissue_phenotype | 0.73130115 |
| 118 | MP0005645_abnormal_hypothalamus_physiol | 0.71895022 |
| 119 | MP0001533_abnormal_skeleton_physiology | 0.70065338 |
| 120 | MP0003724_increased_susceptibility_to | 0.68818087 |
| 121 | MP0002419_abnormal_innate_immunity | 0.66005547 |
| 122 | MP0003566_abnormal_cell_adhesion | 0.65841824 |
| 123 | MP0004742_abnormal_vestibular_system | 0.65671923 |
| 124 | MP0008004_abnormal_stomach_pH | 0.64052397 |
| 125 | MP0001849_ear_inflammation | 0.63618118 |
| 126 | MP0003122_maternal_imprinting | 0.60588070 |
| 127 | MP0002089_abnormal_postnatal_growth/wei | 0.60402012 |
| 128 | MP0000681_abnormal_thyroid_gland | 0.58955170 |
| 129 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.58493334 |
| 130 | MP0006276_abnormal_autonomic_nervous | 0.57886090 |
| 131 | MP0001963_abnormal_hearing_physiology | 0.56781733 |
| 132 | MP0001851_eye_inflammation | 0.55550670 |
| 133 | MP0001177_atelectasis | 0.54501499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Visual hallucinations (HP:0002367) | 4.05041551 |
| 2 | Abnormality of binocular vision (HP:0011514) | 3.95350210 |
| 3 | Diplopia (HP:0000651) | 3.95350210 |
| 4 | Myokymia (HP:0002411) | 3.57871147 |
| 5 | Obstructive sleep apnea (HP:0002870) | 3.50233336 |
| 6 | Supranuclear gaze palsy (HP:0000605) | 3.48647401 |
| 7 | Abnormality of the lower motor neuron (HP:0002366) | 3.45589005 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 3.20185528 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.20185528 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.20185528 |
| 11 | Neurofibrillary tangles (HP:0002185) | 3.17005186 |
| 12 | Action tremor (HP:0002345) | 3.11091513 |
| 13 | Cerebral inclusion bodies (HP:0100314) | 3.09692025 |
| 14 | Focal seizures (HP:0007359) | 3.03244930 |
| 15 | Focal motor seizures (HP:0011153) | 2.98363116 |
| 16 | Progressive cerebellar ataxia (HP:0002073) | 2.94981207 |
| 17 | Mutism (HP:0002300) | 2.80064858 |
| 18 | Ankle clonus (HP:0011448) | 2.78897826 |
| 19 | Diminished motivation (HP:0000745) | 2.75521534 |
| 20 | Axonal loss (HP:0003447) | 2.70653022 |
| 21 | Febrile seizures (HP:0002373) | 2.69808547 |
| 22 | Increased cerebral lipofuscin (HP:0011813) | 2.67028257 |
| 23 | Annular pancreas (HP:0001734) | 2.65414303 |
| 24 | Depression (HP:0000716) | 2.65370621 |
| 25 | Generalized tonic-clonic seizures (HP:0002069) | 2.60510302 |
| 26 | Dysmetric saccades (HP:0000641) | 2.59208953 |
| 27 | Amyloidosis (HP:0011034) | 2.54054142 |
| 28 | Delusions (HP:0000746) | 2.51187186 |
| 29 | Systemic lupus erythematosus (HP:0002725) | 2.49930395 |
| 30 | Epileptic encephalopathy (HP:0200134) | 2.47096211 |
| 31 | Global brain atrophy (HP:0002283) | 2.46344003 |
| 32 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.46330453 |
| 33 | Ventricular fibrillation (HP:0001663) | 2.46139561 |
| 34 | Intention tremor (HP:0002080) | 2.45904612 |
| 35 | Atonic seizures (HP:0010819) | 2.40280208 |
| 36 | Absence seizures (HP:0002121) | 2.40025914 |
| 37 | Peripheral hypomyelination (HP:0007182) | 2.37373667 |
| 38 | Neuronal loss in central nervous system (HP:0002529) | 2.37061094 |
| 39 | Dementia (HP:0000726) | 2.36027506 |
| 40 | Postural instability (HP:0002172) | 2.35830057 |
| 41 | Lower limb amyotrophy (HP:0007210) | 2.35101472 |
| 42 | Bundle branch block (HP:0011710) | 2.34807899 |
| 43 | Nuclear cataract (HP:0100018) | 2.31705415 |
| 44 | Retinal atrophy (HP:0001105) | 2.31187108 |
| 45 | Exercise-induced myalgia (HP:0003738) | 2.30970677 |
| 46 | Agitation (HP:0000713) | 2.30399096 |
| 47 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.28557160 |
| 48 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.28557160 |
| 49 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.28393857 |
| 50 | Purpura (HP:0000979) | 2.28021714 |
| 51 | Torticollis (HP:0000473) | 2.25354544 |
| 52 | Truncal ataxia (HP:0002078) | 2.22918517 |
| 53 | Bradykinesia (HP:0002067) | 2.22579790 |
| 54 | Hand muscle atrophy (HP:0009130) | 2.22024425 |
| 55 | Akinesia (HP:0002304) | 2.21053111 |
| 56 | Pheochromocytoma (HP:0002666) | 2.19878504 |
| 57 | Loss of speech (HP:0002371) | 2.17978089 |
| 58 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.15613851 |
| 59 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.14810581 |
| 60 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.12094672 |
| 61 | Absent/shortened dynein arms (HP:0200106) | 2.12094672 |
| 62 | Distal upper limb amyotrophy (HP:0007149) | 2.10028304 |
| 63 | Upper limb amyotrophy (HP:0009129) | 2.10028304 |
| 64 | Dysdiadochokinesis (HP:0002075) | 2.09920288 |
| 65 | Rapidly progressive (HP:0003678) | 2.09845292 |
| 66 | Spastic tetraparesis (HP:0001285) | 2.09785625 |
| 67 | Clonus (HP:0002169) | 2.09033589 |
| 68 | EEG with generalized epileptiform discharges (HP:0011198) | 2.08967292 |
| 69 | Hypoglycemic seizures (HP:0002173) | 2.08943177 |
| 70 | Dialeptic seizures (HP:0011146) | 2.08235081 |
| 71 | Impaired social interactions (HP:0000735) | 2.07848059 |
| 72 | Abnormal social behavior (HP:0012433) | 2.07848059 |
| 73 | Limb dystonia (HP:0002451) | 2.06751661 |
| 74 | Hypsarrhythmia (HP:0002521) | 2.06356632 |
| 75 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.06038864 |
| 76 | Gout (HP:0001997) | 2.05753210 |
| 77 | Dysostosis multiplex (HP:0000943) | 2.04790114 |
| 78 | Epileptiform EEG discharges (HP:0011182) | 2.03857751 |
| 79 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.02752781 |
| 80 | Genetic anticipation (HP:0003743) | 2.02678853 |
| 81 | Lower limb muscle weakness (HP:0007340) | 2.01797752 |
| 82 | Hypercortisolism (HP:0001578) | 2.00515453 |
| 83 | Ketoacidosis (HP:0001993) | 2.00393366 |
| 84 | Polyphagia (HP:0002591) | 2.00147231 |
| 85 | Postural tremor (HP:0002174) | 1.99598809 |
| 86 | Slow saccadic eye movements (HP:0000514) | 1.99249252 |
| 87 | Termporal pattern (HP:0011008) | 1.99246025 |
| 88 | Insidious onset (HP:0003587) | 1.99246025 |
| 89 | Dysmetria (HP:0001310) | 1.99178596 |
| 90 | Abnormal eating behavior (HP:0100738) | 1.98068304 |
| 91 | Infertility (HP:0000789) | 1.97667986 |
| 92 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.96862458 |
| 93 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.96458644 |
| 94 | Chronic bronchitis (HP:0004469) | 1.95180888 |
| 95 | Insomnia (HP:0100785) | 1.94612436 |
| 96 | Anxiety (HP:0000739) | 1.94160362 |
| 97 | Rigidity (HP:0002063) | 1.94046690 |
| 98 | Distal lower limb amyotrophy (HP:0008944) | 1.93399291 |
| 99 | Large for gestational age (HP:0001520) | 1.93145784 |
| 100 | Cerebral hypomyelination (HP:0006808) | 1.93100687 |
| 101 | Tetraplegia (HP:0002445) | 1.92539437 |
| 102 | Hyperglycemia (HP:0003074) | 1.92197372 |
| 103 | Papilledema (HP:0001085) | 1.90854490 |
| 104 | Mucopolysacchariduria (HP:0008155) | 1.90254051 |
| 105 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.90254051 |
| 106 | Hemiplegia (HP:0002301) | 1.88348524 |
| 107 | Gait ataxia (HP:0002066) | 1.87716905 |
| 108 | Male infertility (HP:0003251) | 1.85702463 |
| 109 | Eczematoid dermatitis (HP:0000976) | 1.85284974 |
| 110 | Hypoglycemic coma (HP:0001325) | 1.85225282 |
| 111 | Poor eye contact (HP:0000817) | 1.85045577 |
| 112 | Sleep apnea (HP:0010535) | 1.84804619 |
| 113 | Abnormality of the Achilles tendon (HP:0005109) | 1.84606023 |
| 114 | Impaired smooth pursuit (HP:0007772) | 1.84492461 |
| 115 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.84242813 |
| 116 | Xanthomatosis (HP:0000991) | 1.83274564 |
| 117 | Distal lower limb muscle weakness (HP:0009053) | 1.82827867 |
| 118 | Abnormality of saccadic eye movements (HP:0000570) | 1.82378133 |
| 119 | Achilles tendon contracture (HP:0001771) | 1.82074787 |
| 120 | Amyotrophic lateral sclerosis (HP:0007354) | 1.82021313 |
| 121 | Megalencephaly (HP:0001355) | 1.82018803 |
| 122 | Scanning speech (HP:0002168) | 1.81637068 |
| 123 | Focal dystonia (HP:0004373) | 1.81548507 |
| 124 | Urinary urgency (HP:0000012) | 1.80823493 |
| 125 | Complement deficiency (HP:0004431) | 1.79836379 |
| 126 | Status epilepticus (HP:0002133) | 1.79434156 |
| 127 | Asymmetric septal hypertrophy (HP:0001670) | 1.78876882 |
| 128 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.78083802 |
| 129 | Abnormality of macrophages (HP:0004311) | 1.77738757 |
| 130 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.77734656 |
| 131 | Neuroendocrine neoplasm (HP:0100634) | 1.76956859 |
| 132 | Cholecystitis (HP:0001082) | 1.76517122 |
| 133 | Abnormal gallbladder physiology (HP:0012438) | 1.76517122 |
| 134 | Memory impairment (HP:0002354) | 1.75818012 |
| 135 | Craniofacial dystonia (HP:0012179) | 1.75407009 |
| 136 | Hemiparesis (HP:0001269) | 1.74177848 |
| 137 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.73504306 |
| 138 | Growth hormone excess (HP:0000845) | 1.73358892 |
| 139 | Apathy (HP:0000741) | 1.72806530 |
| 140 | Cerebral aneurysm (HP:0004944) | 1.72532229 |
| 141 | Abnormality of the periventricular white matter (HP:0002518) | 1.72271706 |
| 142 | Ocular albinism (HP:0001107) | 1.71102822 |
| 143 | Increased CSF protein (HP:0002922) | 1.69924294 |
| 144 | Foot dorsiflexor weakness (HP:0009027) | 1.68865189 |
| 145 | Ketosis (HP:0001946) | 1.68702414 |
| 146 | Spastic gait (HP:0002064) | 1.68452012 |
| 147 | Distal sensory impairment (HP:0002936) | 1.67449826 |
| 148 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.66911956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRKD3 | 3.61754260 |
| 2 | MAP3K9 | 2.83302343 |
| 3 | PDK4 | 2.76172131 |
| 4 | PDK3 | 2.76172131 |
| 5 | TRIB3 | 2.72517985 |
| 6 | MAP3K2 | 2.61876499 |
| 7 | PRPF4B | 2.54557900 |
| 8 | NTRK3 | 2.49985259 |
| 9 | PDK2 | 2.49071601 |
| 10 | KSR2 | 2.32046724 |
| 11 | MAP3K11 | 2.24116085 |
| 12 | MAP3K4 | 2.09275292 |
| 13 | CAMKK1 | 1.88520370 |
| 14 | EPHA4 | 1.84523394 |
| 15 | NTRK1 | 1.82301412 |
| 16 | MINK1 | 1.80148858 |
| 17 | PAK6 | 1.79579724 |
| 18 | DAPK2 | 1.77331730 |
| 19 | MARK1 | 1.70272099 |
| 20 | INSRR | 1.57847422 |
| 21 | FGFR2 | 1.57523424 |
| 22 | RIPK1 | 1.52150572 |
| 23 | MAP2K4 | 1.51887924 |
| 24 | CAMKK2 | 1.50731681 |
| 25 | NTRK2 | 1.47450048 |
| 26 | TYRO3 | 1.45307806 |
| 27 | LMTK2 | 1.43004751 |
| 28 | TESK1 | 1.41017996 |
| 29 | FRK | 1.39141170 |
| 30 | TAOK2 | 1.37306355 |
| 31 | TAOK1 | 1.36032989 |
| 32 | RET | 1.34879380 |
| 33 | LIMK1 | 1.33308956 |
| 34 | MAP3K1 | 1.31822994 |
| 35 | MARK2 | 1.31144355 |
| 36 | PTK2B | 1.29880284 |
| 37 | PAK3 | 1.28998240 |
| 38 | STK38 | 1.21241143 |
| 39 | PRKCH | 1.18833905 |
| 40 | PHKG1 | 1.18294451 |
| 41 | PHKG2 | 1.18294451 |
| 42 | MAP2K7 | 1.13382457 |
| 43 | CDK5 | 1.12125001 |
| 44 | SIK2 | 1.08079318 |
| 45 | IRAK3 | 1.07620298 |
| 46 | TNK2 | 1.07099699 |
| 47 | TESK2 | 1.06687142 |
| 48 | FER | 1.04923347 |
| 49 | PDK1 | 1.01966749 |
| 50 | CAMK1 | 1.01514181 |
| 51 | GRK5 | 1.00474047 |
| 52 | ERN1 | 0.98860155 |
| 53 | PDPK1 | 0.98319772 |
| 54 | WNK4 | 0.96003187 |
| 55 | CDK19 | 0.94249170 |
| 56 | PIM2 | 0.93973363 |
| 57 | PRKCG | 0.91852461 |
| 58 | SGK494 | 0.91761631 |
| 59 | SGK223 | 0.91761631 |
| 60 | PDGFRA | 0.90368713 |
| 61 | MOS | 0.90368403 |
| 62 | PINK1 | 0.90106431 |
| 63 | RIPK4 | 0.89916942 |
| 64 | SCYL2 | 0.89617880 |
| 65 | FES | 0.88404965 |
| 66 | NEK1 | 0.88190103 |
| 67 | ALK | 0.87227877 |
| 68 | ARAF | 0.86845474 |
| 69 | SGK3 | 0.86339907 |
| 70 | BRAF | 0.86317000 |
| 71 | PRKD2 | 0.84597747 |
| 72 | PTK2 | 0.84121941 |
| 73 | MAP2K1 | 0.83326598 |
| 74 | PTK6 | 0.82718975 |
| 75 | DAPK3 | 0.81266851 |
| 76 | CAMK2G | 0.80715415 |
| 77 | CDK18 | 0.80280135 |
| 78 | PLK2 | 0.79914159 |
| 79 | CDK11A | 0.79898341 |
| 80 | CAMK1G | 0.78699382 |
| 81 | MAP3K3 | 0.78418802 |
| 82 | ICK | 0.77516980 |
| 83 | ABL2 | 0.76935119 |
| 84 | MAP2K3 | 0.71767536 |
| 85 | AKT3 | 0.68168272 |
| 86 | EPHA3 | 0.68081999 |
| 87 | WNK1 | 0.66132138 |
| 88 | PKN2 | 0.63499235 |
| 89 | PRKG2 | 0.62273438 |
| 90 | STK11 | 0.60981414 |
| 91 | SGK2 | 0.60182387 |
| 92 | EPHB1 | 0.59286574 |
| 93 | DDR2 | 0.58425498 |
| 94 | BLK | 0.58358005 |
| 95 | MAP3K13 | 0.57806842 |
| 96 | UHMK1 | 0.57423301 |
| 97 | MAPK15 | 0.57356336 |
| 98 | IRAK2 | 0.56058837 |
| 99 | BMX | 0.54998131 |
| 100 | RPS6KA2 | 0.54666035 |
| 101 | LATS2 | 0.54609724 |
| 102 | CAMK2A | 0.52852240 |
| 103 | MAP2K6 | 0.52172105 |
| 104 | FYN | 0.51952907 |
| 105 | TAOK3 | 0.50704774 |
| 106 | TBK1 | 0.50441051 |
| 107 | CAMK4 | 0.50112864 |
| 108 | RAF1 | 0.49457233 |
| 109 | ROCK2 | 0.48918813 |
| 110 | PRKCZ | 0.48340061 |
| 111 | BMPR2 | 0.48083944 |
| 112 | FGFR4 | 0.47428906 |
| 113 | PKN1 | 0.46016667 |
| 114 | KSR1 | 0.45880001 |
| 115 | CDK14 | 0.45310098 |
| 116 | MAPK12 | 0.44748003 |
| 117 | PRKAA1 | 0.44409842 |
| 118 | DMPK | 0.43628618 |
| 119 | CAMK2D | 0.43076170 |
| 120 | DYRK1B | 0.42953804 |
| 121 | PRKCE | 0.42570565 |
| 122 | SIK1 | 0.42393428 |
| 123 | JAK1 | 0.40971366 |
| 124 | CAMK2B | 0.40857933 |
| 125 | MAPK10 | 0.40706936 |
| 126 | PRKACG | 0.40224842 |
| 127 | CDC42BPA | 0.39975410 |
| 128 | FGFR3 | 0.39584963 |
| 129 | MST1R | 0.38562298 |
| 130 | DAPK1 | 0.38042256 |
| 131 | CAMK1D | 0.37588932 |
| 132 | PNCK | 0.37417791 |
| 133 | RPS6KA3 | 0.37338948 |
| 134 | PDGFRB | 0.36484393 |
| 135 | CDK15 | 0.36277776 |
| 136 | PRKD1 | 0.36197742 |
| 137 | JAK2 | 0.35443709 |
| 138 | HIPK2 | 0.35008073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.79678731 |
| 2 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.23916375 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.10975343 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.99580200 |
| 5 | Insulin secretion_Homo sapiens_hsa04911 | 1.93348471 |
| 6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.83563232 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 1.78843181 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 1.73584327 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 1.71913369 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.71230049 |
| 11 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.66699447 |
| 12 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.62275927 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.59474734 |
| 14 | Nicotine addiction_Homo sapiens_hsa05033 | 1.54940732 |
| 15 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.51027155 |
| 16 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.50451152 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.50029110 |
| 18 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.45952798 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.40485085 |
| 20 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.39223574 |
| 21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.36359044 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.35594749 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.35404966 |
| 24 | Morphine addiction_Homo sapiens_hsa05032 | 1.35109330 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.34213473 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.34161871 |
| 27 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.30331318 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.27671100 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.23251353 |
| 30 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.21059756 |
| 31 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.19290268 |
| 32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.15989585 |
| 33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.14810639 |
| 34 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.12706911 |
| 35 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.12553405 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.12157711 |
| 37 | Long-term depression_Homo sapiens_hsa04730 | 1.07375660 |
| 38 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.04771899 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02494251 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.00951119 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00494364 |
| 42 | Taste transduction_Homo sapiens_hsa04742 | 0.99122985 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99031941 |
| 44 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.99028175 |
| 45 | Gap junction_Homo sapiens_hsa04540 | 0.95938787 |
| 46 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.95463644 |
| 47 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.93403912 |
| 48 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.93022665 |
| 49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.92979309 |
| 50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.91017945 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 0.86900113 |
| 52 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.84906381 |
| 53 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.84689642 |
| 54 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.84177090 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.83339121 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.81888259 |
| 57 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.81556787 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 0.80906094 |
| 59 | Glioma_Homo sapiens_hsa05214 | 0.80029958 |
| 60 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.79684910 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77963839 |
| 62 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77642666 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75851193 |
| 64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.75847203 |
| 65 | Tuberculosis_Homo sapiens_hsa05152 | 0.75499208 |
| 66 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.73851928 |
| 67 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.73095671 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.72820402 |
| 69 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71219598 |
| 70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70472797 |
| 71 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70386639 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69873919 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69244993 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68964693 |
| 75 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.67696277 |
| 76 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.67280844 |
| 77 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64194382 |
| 78 | Melanogenesis_Homo sapiens_hsa04916 | 0.64130954 |
| 79 | Circadian rhythm_Homo sapiens_hsa04710 | 0.63663814 |
| 80 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63151447 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.62977708 |
| 82 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62297559 |
| 83 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.61981410 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.60608300 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59801981 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59787919 |
| 87 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.59426712 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59259634 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.58403635 |
| 90 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58042242 |
| 91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.57625145 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.57289375 |
| 93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55926235 |
| 94 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.55568526 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.55497518 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55489022 |
| 97 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.55168451 |
| 98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53882595 |
| 99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53791712 |
| 100 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53056676 |
| 101 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52618199 |
| 102 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52295241 |
| 103 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.52153327 |
| 104 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.51624436 |
| 105 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.51528524 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50852853 |
| 107 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49707254 |
| 108 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.49695232 |
| 109 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.49612873 |
| 110 | Axon guidance_Homo sapiens_hsa04360 | 0.49485399 |
| 111 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49441406 |
| 112 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48396535 |
| 113 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48112153 |
| 114 | Phagosome_Homo sapiens_hsa04145 | 0.47947065 |
| 115 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.47638750 |
| 116 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.46526123 |
| 117 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45823837 |
| 118 | Mineral absorption_Homo sapiens_hsa04978 | 0.45776051 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45630923 |
| 120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44976903 |
| 121 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.44506649 |
| 122 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.44454176 |
| 123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43626258 |
| 124 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43466832 |
| 125 | Platelet activation_Homo sapiens_hsa04611 | 0.43240166 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42493564 |
| 127 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.42056362 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41987385 |
| 129 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41832309 |
| 130 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39150200 |

